Venn Life Sciences Holdings PLC (LON:VENN – Get Free Report)’s stock price passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 6.85 ($0.09) and traded as high as GBX 7 ($0.09). Venn Life Sciences shares last traded at GBX 6.85 ($0.09), with a volume of 1,027,544 shares changing hands.
Venn Life Sciences Stock Performance
The stock has a market cap of £4.89 million and a PE ratio of -2.14. The company has a current ratio of 2.30, a quick ratio of 1.48 and a debt-to-equity ratio of 35.83. The firm has a fifty day simple moving average of GBX 6.85 and a two-hundred day simple moving average of GBX 6.85.
Venn Life Sciences Company Profile
Venn Life Sciences Holdings Plc, a clinical research organization, provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device companies in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. The company offers drug development planning and strategy services, including clinical feasibility assessment, project management, and in-licensing and technical due diligence; and early drug development services, such as drug candidate selection, CMC, non-clinical/pre-clinical development, clinical pharmacology, pharmacokinetics, and pharmacometrics and PK-PD modelling.
Further Reading
- Five stocks we like better than Venn Life Sciences
- How to Use Stock Screeners to Find Stocks
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
- How to Buy Cheap Stocks Step by Step
- MarketBeat Week in Review – 11/18 – 11/22
- Trading Halts Explained
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
Receive News & Ratings for Venn Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venn Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
